Search Videos and More
News
Dana-Farber Research Supports FDA Approval for Immunotherapy Combination in Advanced Kidney Cancer
An immunotherapy agent combined with a tyrosine kinase inhibitor drug whose clinical testing as a first-line treatment in advanced kidney cancer was led by Toni K. Choueiri, MD, Director of the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, has become a standard therapy.
News
Personalized Vaccine Produces Long-Lasting Anti-Tumor Response in Patients with Melanoma, Study Shows
Four years after patients with melanoma were treated with a personalized cancer vaccine, the immune response kindled by the vaccine remains robust and effective in keeping cancer cells under control, researchers at Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and the Broad Institute of MIT and Harvard report in a new study.
News
Study Shows Sharp Decline in Cancer Screenings and Diagnoses During the First Covid-19 Surge
In one of the first studies to examine the impact of the COVID-19 pandemic on cancer diagnoses, researchers at Dana-Farber/Brigham and Women’s Cancer Center document a substantial decline in cancer and precancer diagnoses at the Northeast’s largest health care system during the first peak of the pandemic because of a drop in the number of cancer screening tests performed.
News
Eric P. Winer Elected ASCO President for Term Starting in June 2022
The American Society of Clinical Oncology (ASCO) has elected Eric P. Winer, MD, to serve as its President for the term beginning in June 2022. He will take office as President-Elect during the ASCO Annual Meeting in June 2021. Winer is the chief clinical development officer, senior vice president for medical affairs, chief of the Division of Breast Oncology, and the Thompson Chair in Breast Cancer Research at Dana-Farber Cancer Institute. He is also a professor of medicine at Harvard Medical School.
Video
Dana-Farber Research Looks at Blood Test to Detect Cancer
Dana-Farber’s Deborah Schrag, MD, MPH, is leading the Pathfinder Study, a study that looks at a simple blood test and evaluates it to see if it could detect multiple cancer types at the earliest and most treatable stages.
Video
Communicating With Families of Seriously Ill Patients with COVID-19: What are The Guidelines? Which Models Can Help You Manage These Difficult Conversations?
Richard Leiter, MD, MA, presents on patients with Covid-19 and how to communicate with their families and how to have difficult conversations.
Video
Myeloma Patients Covid-19: How to Keep Myeloma Care Safe During the Pandemic
Nikhil Munshi, MD, discusses Covid-19 and Myeloma, the understanding the disease, how to make the treatments safer all while being aware of Covid-19 protocols.